MedPath

Comparison of primary postoperative needling with anti-glaucoma medication in Ahmed Glaucoma valve (AGV) implantation outcome

Not Applicable
Conditions
Glaucoma.
Primary open-angle glaucoma
H40.11
Registration Number
IRCT20240217061030N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients who recently underwent AGV shunt surgery due to high intraocular pressure and glaucomatous optic nerve damage also their IOP was higher than target pressure
Absence of scarring and extensive fibrosis in the conjunctiva
Not using anti-glaucoma drugs before therapeutic intervention
Observing the presence of fluid around the shunt plate during examination

Exclusion Criteria

Pregnancy
Breastfeeding
Poor cooperation during the examination with the slit lamp or during the needling operation behind the slit lamp
Impossibility of follow-up and frequent patient visits
Identifying eye surface tumors in the studied eye during follow-up or some eye surface diseases that require special interventions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intraocular pressure. Timepoint: 1, 3, 6 months after the intervention. Method of measurement: Goldman tonometry.
Secondary Outcome Measures
NameTimeMethod
umber of antiglaucoma drugs. Timepoint: 1, 3, 6 months after the intervention. Method of measurement: Counting.
© Copyright 2025. All Rights Reserved by MedPath